- Home
- SKYW vs CORT Comparison
SKYW vs CORT Comparison
Compare SKYW & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SKYW | CORT |
|---|---|---|
| Founded | 1972 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Air Freight/Delivery Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.7B |
| IPO Year | 1994 | 2001 |
Fundamental Metrics
Financial Performance| Metric | SKYW | CORT |
|---|---|---|
| Price | $96.78 | $81.56 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 5 |
| Target Price | ★ $123.67 | $96.50 |
| AVG Volume (30 Days) | 367.2K | ★ 985.8K |
| Earning Date | 04-23-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 33.20 | N/A |
| EPS | ★ 2.50 | N/A |
| Revenue | ★ $2,971,963,000.00 | $761,407,000.00 |
| Revenue This Year | $8.35 | $26.08 |
| Revenue Next Year | $3.55 | $26.98 |
| P/E Ratio | $37.54 | ★ N/A |
| Revenue Growth | N/A | ★ 12.79 |
| 52 Week Low | $77.89 | $28.66 |
| 52 Week High | $123.94 | $91.00 |
Technical Indicators
Market Signals| Indicator | SKYW | CORT |
|---|---|---|
| Relative Strength Index (RSI) | 68.80 | 72.86 |
| Support Level | $94.62 | $78.07 |
| Resistance Level | $102.83 | $90.00 |
| Average True Range (ATR) | 2.81 | 3.57 |
| MACD | 1.03 | -0.69 |
| Stochastic Oscillator | 91.94 | 63.27 |
Price Performance
Historical ComparisonAbout SKYW SkyWest Inc.
SkyWest Inc offers commercial air services in the United States, Canada, Mexico, and the Caribbean. Additionally, it leases aircraft to capable users to help generate revenue. SkyWest generally provides regional flights and utilizes smaller, lower-cost aircraft to carry passengers who book tickets through partner airlines. It partners with carriers to fly and operate aircraft for a fee and may use the carriers' brands and ground support to coordinate marketing and transport passengers. The company has two reportable segments: SkyWest Airlines and SWC, which generate maximum revenue, and SkyWest Leasing activities.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.